University of Oxford’s Dr Matthew Wood discusses his work with exosome delivery, an alternative to lipid nanoparticles (LNP) as well as the TransNAT Consortium to overcome delivery obstacles in nucleic acid therapies.
University of Oxford’s Dr Matthew Wood discusses his work with exosome delivery, an alternative to lipid nanoparticles (LNP) as well as the TransNAT Consortium to overcome delivery obstacles in nucleic acid therapies.